Fig. 1.
Hepatitis C viral load (hep C VL) and Model for End-Stage Liver Disease (MELD) score trends in relationship to donor pool size, transplantation date, and treatment with ledipasvir-sofosbuvir. Suitable organs were found shortly after donor pool expansion to include hepatitis C–positive donors. A sustained virologic response was rapidly achieved after ledipasvir-sofosbuvir treatment. OHT, orthotopic heart transplant.